Passage Bio (NYSE:GFL) Research Coverage Started at Bank of America

Bank of America assumed coverage on shares of Passage Bio (NYSE:GFL) in a research report released on Monday, Briefing.com Automated Import reports. The brokerage issued a neutral rating on the stock.

Several other equities research analysts have also issued reports on GFL. Scotiabank assumed coverage on Passage Bio in a research note on Monday. They set an outperform rating and a $23.00 price target for the company. Barclays assumed coverage on Passage Bio in a research note on Monday. They set an equal weight rating and a $20.00 price target for the company. Raymond James assumed coverage on Passage Bio in a research note on Monday. They set an outperform rating and a $18.00 price target for the company. Stifel Nicolaus assumed coverage on Passage Bio in a research note on Monday. They set a buy rating and a $26.00 price target for the company. Finally, Goldman Sachs Group assumed coverage on Passage Bio in a research note on Monday. They set a neutral rating for the company. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Passage Bio has an average rating of Buy and an average target price of $21.38.

NYSE:GFL traded down $0.60 during trading hours on Monday, hitting $13.14. 1,366,400 shares of the company’s stock traded hands, compared to its average volume of 2,322,005. Passage Bio has a 52 week low of $13.00 and a 52 week high of $17.95.

About Passage Bio

GFL Environmental Inc operates as a diversified environmental services company in North America. The company offers non-hazardous solid waste management, infrastructure and soil remediation, and liquid waste management services. Its solid waste management business line includes the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste for municipal, residential, and commercial and industrial customers.

Featured Article: Trading signals using Bollinger bands

Analyst Recommendations for Passage Bio (NYSE:GFL)

Receive News & Ratings for Passage Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Passage Bio and related companies with MarketBeat.com's FREE daily email newsletter.